Evidence map›Paper›PMID 42724943›Full record

ArticleIndian journal of psychiatry2026

Lumateperone-induced mania: A case series.

Varchasvi Mudgal, Prashant Gaurav, Priyash Jain, Kartikay Chaturvedi

Abstract readCase Reports
In one paragraph

Article in Indian journal of psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Varchasvi MudgalDepartment of Psychiatry, Mahatma Gandhi Memorial Medical College, Indore, Madhya Pradesh, India.
Prashant GauravDepartment of Psychiatry, Mahatma Gandhi Memorial Medical College, Indore, Madhya Pradesh, India.
Priyash JainDepartment of Psychiatry, Mahatma Gandhi Memorial Medical College, Indore, Madhya Pradesh, India.
Kartikay ChaturvediDepartment of Psychiatry, Mahatma Gandhi Memorial Medical College, Indore, Madhya Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lumateperone is an approved treatment for bipolar depression with a low reported risk of treatment-emergent mania. However, real-world evidence remains limited. Cases: We describe three adults with bipolar depression who developed manic symptoms within 10-14 days of initiating lumateperone 42 mg/day. Young Mania Rating Scale scores ranged from 26 to 29. Alternative causes were excluded, symptoms resolved after discontinuing lumateperone and optimizing mood stabilizers, and Naranjo scores (7-8) indicated a probable drug association. Conclusion: Lumateperone may precipitate mania in susceptible individuals, highlighting the need for close monitoring during the early treatment period.

Indexed as

Antipsychotic agentsbipolar disordermaniamood stabilizers

Identifiers

PMID42724943
PMCPMC13561462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.